Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

 0.13p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.01
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 2,295.93m
  • Volume: 48,383,268
  • Market Cap: £3.04m

Latest ShareCast News

Graft Polymer to buy Awakn in £4.98m deal

By Michele Maatouk

Date: Monday 16 Dec 2024

(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.13p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.01
52 Week Low 0.12
Volume 48,383,268
Shares Issued 2,295.93m
Market Cap £3.04m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.14% above the market average8.14% above the market average8.14% above the market average8.14% above the market average8.14% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Price Trend
54.61% below the market average54.61% below the market average54.61% below the market average54.61% below the market average54.61% below the market average
53.19% below the sector average53.19% below the sector average53.19% below the sector average53.19% below the sector average53.19% below the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
13:32 2,278,298 @ 0.13p
10:22 56,387 @ 0.13p
09:50 183,110 @ 0.13p
08:13 56,282 @ 0.13p
08:13 1,274 @ 0.13p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page